The negative feedback loop of NF-κB/miR-202-5p/HMGB2 attenuates sepsis induced acute kidney injury

被引:2
作者
Wang, Juan [1 ]
Chen, Jian [2 ]
Li, Zheng [3 ]
Liu, Zhiwen [3 ]
机构
[1] Cent South Univ, Dept Thorac Surg, Xiangya Hosp 2, Changsha, Peoples R China
[2] qi ting jie dao she qu wei sheng fu wu zhong xin, Yixing, Jiangsu, Peoples R China
[3] Cent South Univ, Dept Nephrol, Hunan Key Lab Kidney Dis & Blood Purificat, Xiangya Hosp 2, Changsha, Hunan, Peoples R China
关键词
Sepsis; Acute kidney injury; NF-kappa B; miR-202-5p; HMGB2; Inflammation; NF-KAPPA-B; TUBULE INJURY; INFLAMMATION;
D O I
10.1016/j.intimp.2024.113050
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Sepsis represents a primary cause of acute kidney injury (AKI), yet the underlying mechanisms of septic AKI remain poorly understood. Thus, there exists an urgent need for a deeper understanding of its underlying mechanisms and the development of effective therapeutic strategies. Our study reveals a notable induction in microRNA-202-5p (miR-202-5p) levels within renal tubular cells in septic AKI both in vivo and in vitro models. Treatment of renal tubular cells with LPS induced NF-kappa B kappa B activation, which was linked to the induction of miR202-5p. ChIP assays confirmed NF-kappa B kappa B binding to the miR-202-5p gene promoter upon LPS stimulation. Functionally, miR-202-5p mimics attenuated tubular cell death, kidney injury, and intra-renal inflammatory cytokine production, whereas inhibition of miR-202-5p conferred injurious effects in septic AKI. Notably, miR-202-5p suppressed the expression of High Mobility Group Box 2 (HMGB2) in both in vitro and in vivo septic AKI models. Luciferase microRNA target assays further validated HMGB2 as a direct target of miR-202-5p. Knockdown of HMGB2 inhibits LPS-induced NF-kappa B kappa B activation in septic AKI, as evidenced by HMGB2 siRNA transfection significantly inhibited the nuclear translocation of NF-kappa B. kappa B. Together, these findings elucidate the NF-kappa B/miR-202- kappa B/miR-202- 5p/HMGB2 negative feedback loop which can attenuate kidney injury by inhibiting renal inflammation in septic AKI. Our findings open new avenues for developing targeted therapies to manage septic AKI effectively.
引用
收藏
页数:11
相关论文
共 32 条
[1]   MicroRNAs, new effectors and regulators of NF-κB [J].
Boldin, Mark P. ;
Baltimore, David .
IMMUNOLOGICAL REVIEWS, 2012, 246 :205-220
[2]   NF-?B: blending metabolism, immunity, and inflammation [J].
Capece, Daria ;
Verzella, Daniela ;
Flati, Irene ;
Arboretto, Paola ;
Cornice, Jessica ;
Franzoso, Guido .
TRENDS IN IMMUNOLOGY, 2022, 43 (09) :757-775
[3]   Detrimental cross-talk between sepsis and acute kidney injury: new pathogenic mechanisms, early biomarkers and targeted therapies [J].
Dellepiane, Sergio ;
Marengo, Marita ;
Cantaluppi, Vincenzo .
CRITICAL CARE, 2016, 20
[4]   NF-κB in biology and targeted therapy: new insights and translational implications [J].
Guo, Qing ;
Jin, Yizi ;
Chen, Xinyu ;
Ye, Xiaomin ;
Shen, Xin ;
Lin, Mingxi ;
Zeng, Cheng ;
Zhou, Teng ;
Zhang, Jian .
SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2024, 9 (01)
[5]   MicroRNA-375 Is Induced in Cisplatin Nephrotoxicity to Repress Hepatocyte Nuclear Factor 1-β [J].
Hao, Jielu ;
Lou, Qiang ;
Wei, Qingqing ;
Mei, Shuqin ;
Li, Lin ;
Wu, Guangyu ;
Mi, Qing-Sheng ;
Mei, Changlin ;
Dong, Zheng .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2017, 292 (11) :4571-4582
[6]   NF-κB in immunobiology [J].
Hayden, Matthew S. ;
Ghosh, Sankar .
CELL RESEARCH, 2011, 21 (02) :223-244
[7]   Immune cells in experimental acute kidney injury [J].
Jang, Hye Ryoun ;
Rabb, Hamid .
NATURE REVIEWS NEPHROLOGY, 2015, 11 (02) :88-101
[8]   The Pathophysiology of Sepsis-Associated AKI [J].
Kuwabara, Shuhei ;
Goggins, Eibhlin ;
Okusa, Mark D. .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 17 (07) :1050-1069
[9]   How Tubular Epithelial Cell Injury Contributes to Renal Fibrosis [J].
Liu, Bi-Cheng ;
Tang, Tao-Tao ;
Lv, Lin-Li .
RENAL FIBROSIS: MECHANISMS AND THERAPIES, 2019, 1165 :233-252
[10]   Renal tubule injury: a driving force toward chronic kidney disease [J].
Liu, Bi-Cheng ;
Tang, Tao-Tao ;
Lv, Lin-Li ;
Lan, Hui-Yao .
KIDNEY INTERNATIONAL, 2018, 93 (03) :568-579